Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Jose Villasboas"'
Autor:
William G. Breen, Jason R. Young, Matthew A. Hathcock, Roman O. Kowalchuk, Matthew P. Thorpe, Radhika Bansal, Arushi Khurana, N. Nora Bennani, Jonas Paludo, Jose Villasboas Bisneto, Yucai Wang, Stephen M. Ansell, Jennifer L. Peterson, Patrick B. Johnston, Scott C. Lester, Yi Lin
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-5 (2023)
Abstract PET/CT is used to evaluate relapsed/refractory non-Hodgkin lymphoma (NHL) prior to chimeric antigen receptor T-cell (CAR-T) infusion at two time points: pre-leukapheresis (pre-leuk) and pre-lymphodepletion chemotherapy (pre-LD). We hypothesi
Externí odkaz:
https://doaj.org/article/2216cd6058cc41c898d1c89beb34f7cd
Autor:
Aung M. Tun, Yucai Wang, Seth Maliske, Ivana Micallef, David J. Inwards, Thomas M. Habermann, Luis Porrata, Jonas Paludo, Jose Villasboas Bisneto, Allison Rosenthal, Mohamed A Kharfan-Dabaja, Stephen M. Ansell, Grzegorz S. Nowakowski, Umar Farooq, Patrick B. Johnston
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Chimeric antigen receptor T-cell (CAR-T) therapy is the new standard of care in fit patients with refractory or early relapsed diffuse large B-cell lymphoma (DLBCL). However, there may still be a role for salvage chemotherapy (ST) and autologous stem
Externí odkaz:
https://doaj.org/article/46ad365a880749dfb154a7d75af7f42c
Autor:
Marissa Z. Powell, Kristin C. Mara, Radhika Bansal, Matthew A. Hathcock, Arushi Khurana, N. Nora Bennani, Yucai Wang, Jonas Paludo, Jose Villasboas Bisneto, Stephen M. Ansell, Patrick B. Johnston, Yi Lin, Jason N. Barreto
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9228-9235 (2023)
Abstract Background It is unknown whether serum procalcitonin (PCT) concentration monitoring can differentiate between bacterial infection or cytokine release syndrome (CRS) when chimeric antigen receptor T‐cell (CAR‐T) recipients present with a
Externí odkaz:
https://doaj.org/article/65bcf77c6690463b81ed357ef8602236
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/7b7e3d8ab1824c8fa9da483dd4ff7783
Autor:
Ana Maia, Stephen Ansell, Philippe Armand, Cécile Gouttefangeas, Jonathan W Friedberg, Alice Talpin, Jerome Kervevan, Lucie Aubergeon, Tifanny Mersceman Blanc, Diana Bachrouche, Chloé Ventujol, Léa Bernard, Amandine Manteau, Jose Villasboas, Antonello Pinto, Francesc Bosch, Ramon García-Sanz, Carlos Grande Garcia, Stephen D Smith, Luca Arcaini, Reid Merryman, Pier Zinzani, Christophe Bonny, Laurent Chene, Joao Gamelas Magalhaes
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d0357becdb654800aec9bb511535a03b
Autor:
Michał Taszner, Stefano Luminari, Seok-Goo Cho, Silvana Novelli, Steven Le Gouill, Michelle Poon, Jose Villasboas, Rebecca Champion, Emmanuel Bachy, Stephanie Guidez, Aránzazu Alonso Alonso, Deepa Jagadeesh, Michele Merli, David Tucker, Jingxian Cai, Carolina Leite de Oliveira, Min Zhu, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Tae Min Kim
Publikováno v:
HemaSphere, Vol 7, p e214536e (2023)
Externí odkaz:
https://doaj.org/article/5439b0413b664b68bbe3cb52f1a924ba
Autor:
Zhi-Zhang Yang, Xinyi Tang, Hyo Jin Kim, Vaishali Bhardwaj, Prithviraj Mukherjee, Patrizia Mondello, Jose Villasboas, Anne Novak, Stephen Ansell
Publikováno v:
HemaSphere, Vol 7, p e5464225 (2023)
Externí odkaz:
https://doaj.org/article/e07b181a1f26467eaeb8bb363d40e07a
Autor:
Aung M. Tun, Yucai Wang, Aasiya Matin, David J. Inwards, Thomas M. Habermann, Ivana Micallef, Patrick B. Johnston, Luis Porrata, Jonas Paludo, Jose Villasboas Bisneto, Allison Rosenthal, Han W. Tun, James R. Cerhan, Thomas E. Witzig, Grzegorz S. Nowakowski, Stephen M. Ansell
Publikováno v:
HemaSphere, Vol 7, Iss 4, p e869 (2023)
Immune checkpoint inhibitors (ICIs) and brentuximab vedotin (BV) are novel agents for classic Hodgkin lymphoma, including relapse after autologous stem cell transplant (ASCT). However, their impact on survival post-ASCT relapse, in comparison with co
Externí odkaz:
https://doaj.org/article/a4ab29ec31e74a8da4ff4f0b41f86131
Autor:
Shahrzad Jalali, Tammy Price-Troska, Jonas Paludo, Jose Villasboas, Hyo-Jin Kim, Zhi-Zhang Yang, Anne J. Novak, Stephen M. Ansell
Publikováno v:
Blood Advances, Vol 2, Iss 15, Pp 1985-1997 (2018)
Abstract: Although immune checkpoint molecules regulate the progression of certain cancers, their significance in malignant development of Waldenstrom macroglobulinemia (WM), an incurable low-grade B-cell lymphoma, remains unknown. Recently, cytokine
Externí odkaz:
https://doaj.org/article/dfcd4c94e7814ef6856bf7d1fb3ac25d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.